[HTML][HTML] Targeting cardiac hypertrophy: toward a causal heart failure therapy
E Bisping, P Wakula, M Poteser… - Journal of …, 2014 - journals.lww.com
Cardiac hypertrophy is commonly observed in conditions of increased hemodynamic or
metabolic stress. This hypertrophy is not compensatory but rather reflects activation of …
metabolic stress. This hypertrophy is not compensatory but rather reflects activation of …
[HTML][HTML] III Diretriz brasileira de insuficiência cardíaca crônica
EA Bocchi, FGM Braga, SMA Ferreira… - Arquivos Brasileiros …, 2009 - SciELO Brasil
O objetivo desta Diretriz é servir de apoio e auxiliar os médicos nas decisões referentes aos
seus pacientes, elaborando orientações que podem ser úteis na prática médica. A adoção …
seus pacientes, elaborando orientações que podem ser úteis na prática médica. A adoção …
Calcium antagonists: effects on cardio-renal risk in hypertensive patients
S Nathan, CJ Pepine, GL Bakris - Hypertension, 2005 - Am Heart Assoc
Calcium antagonists comprise 2 main subclasses, dihydropyridines and
nondihydropyridines, and have been studied extensively in hypertensive patients. Early …
nondihydropyridines, and have been studied extensively in hypertensive patients. Early …
Antiarrhythmic engineering of skeletal myoblasts for cardiac transplantation
MR Abraham, CA Henrikson, L Tung… - Circulation …, 2005 - Am Heart Assoc
Skeletal myoblasts are an attractive cell type for transplantation because they are
autologous and resistant to ischemia. However, clinical trials of myoblast transplantation in …
autologous and resistant to ischemia. However, clinical trials of myoblast transplantation in …
[HTML][HTML] Selective blockade of Cav1.2 (α1C) versus Cav1.3 (α1D) L-type calcium channels by the black mamba toxin calciseptine
P Mesirca, J Chemin, C Barrère, E Torre… - Nature …, 2024 - nature.com
L-type voltage-gated calcium channels are involved in multiple physiological functions.
Currently available antagonists do not discriminate between L-type channel isoforms …
Currently available antagonists do not discriminate between L-type channel isoforms …
[HTML][HTML] Decreased cardiac L-type Ca2+ channel activity induces hypertrophy and heart failure in mice
SA Goonasekera, K Hammer… - The Journal of …, 2012 - Am Soc Clin Investig
Antagonists of L-type Ca2+ channels (LTCCs) have been used to treat human
cardiovascular diseases for decades. However, these inhibitors can have untoward effects …
cardiovascular diseases for decades. However, these inhibitors can have untoward effects …
[HTML][HTML] Amlodipine
KG Bulsara, M Cassagnol - 2018 - europepmc.org
Objectives: Identify the uses and indications of amlodipine; both approved and off-label.
Describe the mechanism of action of amlodipine. Summarize the adverse drug reactions of …
Describe the mechanism of action of amlodipine. Summarize the adverse drug reactions of …
Y-27632 preconditioning enhances transplantation of human-induced pluripotent stem cell-derived cardiomyocytes in myocardial infarction mice
Aims The effectiveness of cell-based treatments for regenerative myocardial therapy is
limited by low rates of cell engraftment. Y-27632 inhibits Rho-associated protein kinase …
limited by low rates of cell engraftment. Y-27632 inhibits Rho-associated protein kinase …
[HTML][HTML] Aberrant Splicing Promotes Proteasomal Degradation of L-type CaV1.2 Calcium Channels by Competitive Binding for CaVβ Subunits in Cardiac …
Decreased expression and activity of CaV1. 2 calcium channels has been reported in
pressure overload-induced cardiac hypertrophy and heart failure. However, the underlying …
pressure overload-induced cardiac hypertrophy and heart failure. However, the underlying …
[HTML][HTML] Therapeutic use of the rebound effect of modern drugs:" New homeopathic medicines"
MZ Teixeira - Revista da Associação Médica Brasileira, 2017 - SciELO Brasil
The homeopathic treatment is based on the principle of therapeutic similitude, employing
medicines that cause certain disorders to treat similar manifestations, stimulating a reaction …
medicines that cause certain disorders to treat similar manifestations, stimulating a reaction …